News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tsumura & Co. , Dainippon Pharmaceutical To Cease Development Of Lercanidipine Hydrochloride, Hypertension Drug Candidate


10/19/2005 5:09:04 PM

Tokyo, Japan, Aug 02, 2005 (JCN Newswire via COMTEX) -- Tsumura and Dainippon Pharmaceutical have decided to return their right to develop and sell lercanidipine hydrochloride, a hypertension drug candidate, in Japan to Recordati, an Italian pharmaceutical.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES